Top

Published in:

01-08-2009 | Commentary

When once is not enough – further evidence of procalcitonin-guided antibiotic stewardship

Authors: Stephan Harbarth, Werner C Albrich, Beat Müller

Published in: Critical Care | Issue 4/2009

Abstract

Every day, critical care physicians around the world face the same challenge of the optimal timing of antimicrobial administration: when to start and when to stop antibiotics. Duration of antibiotic therapy for sepsis is mostly based on expert opinion, but its reduction is arguably the most promising approach to decrease emergence and selection of antibiotic resistance. The study by Hochreiter and colleagues presents another piece of evidence suggesting that procalcitonin may indeed be a valuable diagnostic parameter to guide antibiotic treatment duration, despite the ongoing controversy about the diagnostic accuracy of pro-calcitonin.

Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009, 13: R83. 10.1186/cc7903PubMedCentralCrossRefPubMed

Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007,44(Suppl 2):S27-S72. 10.1086/511159CrossRefPubMed

Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, for the PneumA Trial Group: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290: 2588-2598. 10.1001/jama.290.19.2588CrossRefPubMed

Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME: Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs 2008, 68: 1841-1854. 10.2165/00003495-200868130-00004CrossRefPubMed

Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M: Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008, 168: 2000-2007. discussion 2007–2008. 10.1001/archinte.168.18.2000CrossRefPubMed

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8CrossRefPubMed

Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174: 84-93. 10.1164/rccm.200512-1922OCCrossRefPubMed

Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, Huber P, Muller B, Tamm M: Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007, 131: 9-19. 10.1378/chest.06-1500CrossRefPubMed

Procalcitonin Reduces Antibiotic Treatments in Acute-ill Patients (PRORATA)[http://clinicaltrials.gov/ct2/show/NCT00472667]

10.

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177: 498-505. 10.1164/rccm.200708-1238OCCrossRefPubMed

11.

Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schonenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B, for the ProHOSP study group: Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007, 7: 102. 10.1186/1472-6963-7-102PubMedCentralCrossRefPubMed

12.

Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroder S: Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy. Anaesthesist 2008, 57: 571-577. 10.1007/s00101-008-1379-xCrossRefPubMed

13.

Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T: Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009, 394: 221-226. 10.1007/s00423-008-0432-1CrossRefPubMed

14.

Nylen E, Muller B, Becker KL, Snider R: The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 2003, 36: 823-824. author reply 826–827. 10.1086/368088CrossRefPubMed

15.

Christ-Crain M, Muller B: Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005, 135: 451-460.PubMed

16.

Shehabi Y, Seppelt I: Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 2008, 12: 211. 10.1186/cc6860PubMedCentralCrossRefPubMed

Title: When once is not enough – further evidence of procalcitonin-guided antibiotic stewardship
Authors: Stephan Harbarth
Werner C Albrich
Beat Müller
Publication date: 01-08-2009
Publisher: BioMed Central
Published in: Critical Care / Issue 4/2009
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc7935

Keynote webinar | Spotlight on medication adherence

Springer Medicine

When once is not enough – further evidence of procalcitonin-guided antibiotic stewardship

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Bench-to-bedside review: Mobilizing patients in the intensive care unit – from pathophysiology to clinical trials

Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?

Who is at increased risk for acute kidney injury following noncardiac surgery?

Advanced glycation endproducts in sepsis and mechanical ventilation: extra or leading man?

Bench-to-bedside review: The promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection

Serum Interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study